AUD202.73
1.97% today
Australia, Apr 03, 07:10 am CET
ISIN
AU000000PME8
Symbol
PME

Pro Medicus Target price 2025 - Analyst rating & recommendation

Pro Medicus Classifications & Recommendation:

Buy
33%
Hold
53%
Sell
13%

Pro Medicus Price Target

Target Price AUD268.66
Price AUD202.73
Potential
Number of Estimates 14
14 Analysts have issued a price target Pro Medicus 2026 . The average Pro Medicus target price is AUD268.66. This is higher than the current stock price. The highest price target is
AUD310.00 52.91%
register free of charge
, the lowest is
AUD165.00 18.61%
register free of charge
.
A rating was issued by 15 analysts: 5 Analysts recommend Pro Medicus to buy, 8 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Pro Medicus stock has an average upside potential 2026 of . Most analysts recommend the Pro Medicus stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million AUD 161.50 212.95
29.30% 31.86%
EBITDA Margin 74.77% 76.78%
1.73% 2.68%
Net Margin 51.12% 53.66%
5.34% 4.97%

14 Analysts have issued a sales forecast Pro Medicus 2025 . The average Pro Medicus sales estimate is

AUD213m
Unlock
. This is
15.37% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD220m 18.94%
Unlock
, the lowest is
AUD207m 12.15%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 AUD162m 29.30%
2025
AUD213m 31.86%
Unlock
2026
AUD290m 35.95%
Unlock
2027
AUD383m 32.45%
Unlock
2028
AUD486m 26.87%
Unlock

14 Analysts have issued an Pro Medicus EBITDA forecast 2025. The average Pro Medicus EBITDA estimate is

AUD163m
Unlock
. This is
16.37% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD174m 23.84%
Unlock
, the lowest is
AUD156m 11.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 AUD121m 31.55%
2025
AUD163m 35.39%
Unlock
2026
AUD228m 39.51%
Unlock
2027
AUD309m 35.63%
Unlock
2028
AUD417m 34.84%
Unlock

EBITDA Margin

2024 74.77% 1.73%
2025
76.78% 2.68%
Unlock
2026
78.78% 2.60%
Unlock
2027
80.68% 2.41%
Unlock
2028
85.74% 6.27%
Unlock

6 Pro Medicus Analysts have issued a net profit forecast 2025. The average Pro Medicus net profit estimate is

AUD114m
Unlock
. This is
16.34% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD122m 23.72%
Unlock
, the lowest is
AUD110m 12.12%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 AUD82.6m 36.21%
2025
AUD114m 38.43%
Unlock
2026
AUD164m 43.64%
Unlock
2027
AUD222m 35.09%
Unlock
2028
AUD300m 35.28%
Unlock

Net Margin

2024 51.12% 5.34%
2025
53.66% 4.97%
Unlock
2026
56.70% 5.67%
Unlock
2027
57.83% 1.99%
Unlock
2028
61.66% 6.62%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share AUD 0.79 1.09
36.21% 37.97%
P/E 181.80
EV/Sales 96.69

6 Analysts have issued a Pro Medicus forecast for earnings per share. The average Pro Medicus EPS is

AUD1.09
Unlock
. This is
15.96% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
AUD1.16 23.40%
Unlock
, the lowest is
AUD1.05 11.70%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 AUD0.79 36.21%
2025
AUD1.09 37.97%
Unlock
2026
AUD1.57 44.04%
Unlock
2027
AUD2.12 35.03%
Unlock
2028
AUD2.87 35.38%
Unlock

P/E ratio

Current 211.28 35.93%
2025
181.80 13.95%
Unlock
2026
126.56 30.39%
Unlock
2027
93.69 25.97%
Unlock
2028
69.26 26.08%
Unlock

Based on analysts' sales estimates for 2025, the Pro Medicus stock is valued at an EV/Sales of

96.69
Unlock
and an P/S ratio of
97.53
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 111.55 48.12%
2025
96.69 13.32%
Unlock
2026
71.12 26.44%
Unlock
2027
53.69 24.50%
Unlock
2028
42.32 21.18%
Unlock

P/S ratio

Current 112.53 47.61%
2025
97.53 13.32%
Unlock
2026
71.74 26.44%
Unlock
2027
54.16 24.50%
Unlock
2028
42.69 21.18%
Unlock

Current Pro Medicus Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
WILSONS
Locked
Locked
Locked Jan 06 2025
BELL POTTER SECURITIES
Locked
Locked
Locked Dec 04 2024
E&P
Locked
Locked
Locked Nov 28 2024
MACQUARIE RESEARCH
Locked
Locked
Locked Nov 18 2024
MACQUARIE RESEARCH
Locked
Locked
Locked Oct 28 2024
Analyst Rating Date
Locked
WILSONS:
Locked
Locked
Jan 06 2025
Locked
BELL POTTER SECURITIES:
Locked
Locked
Dec 04 2024
Locked
E&P:
Locked
Locked
Nov 28 2024
Locked
MACQUARIE RESEARCH:
Locked
Locked
Nov 18 2024
Locked
MACQUARIE RESEARCH:
Locked
Locked
Oct 28 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today